Crossmark

Uncovering the mechanisms of diosmin in treating obesity-related kidney injury based on network pharmacology, molecular docking, and in vitro validation

Crossref DOI link: https://doi.org/10.1007/s00210-024-03398-9

Published Online: 2024-09-02

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhu, Jun-Xing

Chu, Fan

Zhao, Wen-Man

Shi, Rui

Wang, Zhi-Juan

Li, Xun-Liang

Zhu, Yu-Yu

Wang, De-Guang
Funding

Funding for this research was provided by:

the Natural Science Foundation of the Anhui Province (2008085MH244)
License Information

Text and Data Mining valid from 2024-09-02

Version of Record valid from 2024-09-02
More Information

Article History

Received: 2 July 2024

Accepted: 18 August 2024

First Online: 2 September 2024

Declarations

:

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below